Therapeutic dormancy to delay postsurgical glioma recurrence: the past, present and promise of focal hypothermia Didier Wion Topic Review 17 May 2017 Pages: 447 - 454
The role of bevacizumab in the treatment of glioblastoma Roberto Jose DiazSheikh AliRicardo J. Komotar Topic Review 19 May 2017 Pages: 455 - 467
Next-Generation Sequencing-based genomic profiling of brain metastases of primary ovarian cancer identifies high number of BRCA-mutations S. BalendranS. Liebmann-ReindlM. Preusser Laboratory Investigation Open access 11 May 2017 Pages: 469 - 476
MiR-181b modulates chemosensitivity of glioblastoma multiforme cells to temozolomide by targeting the epidermal growth factor receptor Yunxiang ChenRui LiXiefeng Wang Laboratory Investigation 13 May 2017 Pages: 477 - 485
Study of β-catenin and BRAF alterations in adamantinomatous and papillary craniopharyngiomas: mutation analysis with immunohistochemical correlation in 54 cases Prit Benny MalgulwarAruna NambirajanMehar Chand Sharma Laboratory Investigation 12 May 2017 Pages: 487 - 495
Epithelial growth factor receptor expression influences 5-ALA induced glioblastoma fluorescence Andrea O. FontanaDeborah PiffarettiMichael Reinert Laboratory Investigation Open access 12 May 2017 Pages: 497 - 507
Epigenetically controlled Six3 expression regulates glioblastoma cell proliferation and invasion alongside modulating the activation levels of WNT pathway members Baoxin ZhangChenfu ShenZuping Zhang Laboratory Investigation 22 June 2017 Pages: 509 - 518
Evaluation of mitochondrial respiratory function in highly glycolytic glioma cells reveals low ADP phosphorylation in relation to oxidative capacity Erika Rodrigues-SilvaEdilene S. Siqueira-SantosRoger F. Castilho Laboratory Investigation 24 May 2017 Pages: 519 - 529
Radiotherapy for cranial and brain metastases from prostate cancer: a systematic review Timothy L. SitaKatarina G. PetrasTim J. Kruser Clinical Study 25 May 2017 Pages: 531 - 538
Analysis of surgical and MRI factors associated with cerebellar mutism Anjali SergeantMichelle Masayo Kameda-SmithNina Stein Clinical Study 19 May 2017 Pages: 539 - 552
MicroRNA-211 expression is down-regulated and associated with poor prognosis in human glioma Jun ZhangJianguang LvYuqian Li Clinical Study 27 May 2017 Pages: 553 - 559
Nivolumab for patients with recurrent glioblastoma progressing on bevacizumab: a retrospective case series Marc C. ChamberlainBryan T. Kim Clinical Study 12 May 2017 Pages: 561 - 569
Ischemic stroke and intracranial hemorrhage in patients with recurrent glioblastoma multiforme, treated with bevacizumab Timo A. AuerMirjam RenovanzYasemin Tanyildizi Clinical Study 29 May 2017 Pages: 571 - 579
Embryonal tumors in Canadian children less than 36 months of age: results from the Canadian Pediatric Brain Tumor Consortium (CPBTC) E. StoryD. L. JohnstonD. L. Keene Clinical Study 16 May 2017 Pages: 581 - 587
A phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomas Priya KumthekarSean GrimmJeffrey Raizer Clinical Study 16 May 2017 Pages: 589 - 594
Radiation necrosis with stereotactic radiosurgery combined with CTLA-4 blockade and PD-1 inhibition for treatment of intracranial disease in metastatic melanoma Penny FangWen JiangJing Li Clinical Study 12 May 2017 Pages: 595 - 602
Seizure response to perampanel in drug-resistant epilepsy with gliomas: early observations Charles VechtAlberto Duran-PeñaGilles Huberfeld Clinical Study 10 May 2017 Pages: 603 - 607
Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas Susan ByrneSteve ConnorRosalie E. Ferner Clinical Study Open access 07 June 2017 Pages: 609 - 614
MGMT promoter methylation status as a prognostic factor for the outcome of gamma knife radiosurgery for recurrent glioblastoma Byung Sup KimDoo-Sik KongJung-Il Lee Clinical Study 23 May 2017 Pages: 615 - 622
Health-related quality of life outcomes from CABARET: a randomized phase 2 trial of carboplatin and bevacizumab in recurrent glioblastoma Kathryn M. FieldMadeleine T. KingAnna K. Nowak Clinical Study 22 May 2017 Pages: 623 - 631
Diffuse midline skull base meningiomas: identification of a rare and aggressive subgroup of meningiomas Matthieu PeyreLoïc FeuvretMichel Kalamarides Clinical Study 23 May 2017 Pages: 633 - 639
The Simpson grading in meningioma surgery: does the tumor location influence the prognostic value? Kira Marie VoßDorothee Cäcilia SpilleBenjamin Brokinkel Clinical Study 19 May 2017 Pages: 641 - 651
Factors associated with supportive care needs in glioma patients in the neuro-oncological outpatient setting Mirjam RenovanzMarlene HechtnerAnne-Katrin Hickmann Clinical Study 19 May 2017 Pages: 653 - 662
Rapid resolution of leptomeningeal disease with targeted therapy in a metastatic melanoma patient Isabella C. GlitzaSherise D. FergusonNandita Guha-Thakurta Letter to the Editor 20 May 2017 Pages: 663 - 665
MGMT promoter methylation status: time for a frank discussion Niamh ColemanLeslie BridgesFrank Saran Letter to the Editor 30 May 2017 Pages: 667 - 668